Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04955795 · ClinicalTrials.gov registry record · NA

Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA

A NA study of HIV and Alcohol Problem, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
308
Enrollment target
5
Study locations

NCT04955795 is a NA study of HIV and Alcohol Problem that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 308 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (30% lower). The trial reports 5 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04955795, a NA study of HIV and Alcohol Problem, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
308 participants
Enrollment target
5
Study locations

Study Summary

This study is designed to examine the efficacy of a brief intervention plus a cognitive-behavioral intervention compared to brief intervention alone to address unhealthy alcohol use and comorbid mental health symptoms to improve HIV outcomes among people living with HIV in Alabama.

Conditions Studied

Interventions

  • BEHAVIORAL Alcohol Brief Intervention (BI)
  • BEHAVIORAL Common Elements Treatment Approach (CETA) via Telemedicine

Study Locations (5)

Alabama

  • Health Service Center - Anniston
  • UAB Family Clinic - Birmingham
  • Thrive - Huntsville
  • Five Horizons - Montgomery
  • Unity Wellness - Opelika

Trial Details

FieldValue
Enrollment Target 308 participants
Start Date 2023-05-04
Est. Completion 2027-09-30
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT04955795

The ClinicalTrials.gov registry entry for NCT04955795 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 308 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (30% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Alcohol Brief Intervention (BI) is the first listed.

NCT04955795 reports 5 study locations spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT04955795 about?

NCT04955795 is a clinical study titled "Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA". This study is designed to examine the efficacy of a brief intervention plus a cognitive-behavioral intervention compared to brief intervention alone to address unhealthy alcohol use and comorbid mental health symptoms to improve HIV outcomes among people living with HIV in Alabama.

What is the current status of trial NCT04955795?

This trial is currently recruiting. It is a NA study. The enrollment target is 308 participants. The study started on 2023-05-04. Estimated completion is 2027-09-30.

What conditions does trial NCT04955795 study?

This clinical trial studies the following conditions: HIV, Alcohol Problem.

What interventions are being tested in trial NCT04955795?

The interventions under investigation include: Alcohol Brief Intervention (BI) (BEHAVIORAL), Common Elements Treatment Approach (CETA) via Telemedicine (BEHAVIORAL).

Who is sponsoring clinical trial NCT04955795?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04955795 being conducted?

This trial has 5 study locations across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.